JAMIE RAISOR: Open Payments
NPI 1235392424 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,041 in 142 payments from 17 companies in 2025. Trend: 2023 $2,017 · 2024 $3,049 · 2025 $3,041
Food & beverage: $2,956Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $556 |
| GENZYME CORPORATION | 9 | $368 |
| Amgen Inc. | 9 | $254 |
| Regeneron Healthcare Solutions, Inc. | 8 | $240 |
| Galderma Laboratories, L.P. | 21 | $229 |
| PFIZER INC. | 11 | $196 |
| Janssen Biotech, Inc. | 7 | $191 |
| Organon LLC | 4 | $163 |
| Lilly USA, LLC | 13 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $162 |
Products named: DUPIXENT, RINVOQ, OTEZLA, CIBINQO, TREMFYA, SKYRIZI, VTAMA, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
